FIELD: medicine.
SUBSTANCE: invention relates to using of N-methyl-N[(S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-biphenylacetamide or pharmaceutically acceptable salt thereof to produce drug for treatment of urinary bladder disorders. Also disclosed are pharmaceutical composition containing such compound.
EFFECT: agent for complex normalizing of bladder functions, in particular analgesic effect.
4 cl
Authors
Dates
2007-10-10—Published
2002-03-13—Filed